Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

The Novel Bromodomain and Extraterminal Domain Inhibitor INCB054329 Induces Vulnerabilities in Myeloma Cells That Inform Rational Combination Strategies.

Stubbs MC, Burn TC, Sparks RB, Maduskuie T, Diamond S, Rupar M, Wen X, Volgina A, Zolotarjova N, Waeltz P, Favata M, Jalluri R, Liu H, Liu XM, Li J, Collins R, Falahatpisheh N, Polam P, DiMatteo D, Feldman P, Dostalik V, Thekkat P, Gardiner C, He X, Li Y, Covington M, Wynn R, Ruggeri B, Yeleswaram S, Xue C, Yao W, Combs AP, Huber R, Hollis G, Scherle P, Liu P.

Clin Cancer Res. 2018 Sep 11. pii: clincanres.0098.2018. doi: 10.1158/1078-0432.CCR-18-0098. [Epub ahead of print]

PMID:
30206163
2.

Binding Assays for Bromodomain Proteins: Their Utility in Drug Discovery in Oncology and Inflammatory Disease.

Zolotarjova NI, Wynn R.

Curr Protoc Pharmacol. 2018 Mar;80(1):3.16.1-3.16.14. doi: 10.1002/cpph.35.

PMID:
30040205
3.

Multi-component immunoaffinity subtraction and reversed-phase chromatography of human serum.

Martosella J, Zolotarjova N.

Methods Mol Biol. 2008;425:27-39. doi: 10.1007/978-1-60327-210-0_3.

PMID:
18369884
4.

Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum.

Zolotarjova N, Mrozinski P, Chen H, Martosella J.

J Chromatogr A. 2008 May 2;1189(1-2):332-8. Epub 2007 Dec 4.

PMID:
18154976
5.

High recovery HPLC separation of lipid rafts for membrane proteome analysis.

Martosella J, Zolotarjova N, Liu H, Moyer SC, Perkins PD, Boyes BE.

J Proteome Res. 2006 Jun;5(6):1301-12.

PMID:
16739982
6.
7.

Differences among techniques for high-abundant protein depletion.

Zolotarjova N, Martosella J, Nicol G, Bailey J, Boyes BE, Barrett WC.

Proteomics. 2005 Aug;5(13):3304-13.

PMID:
16052628
8.

Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry.

Maccarrone G, Milfay D, Birg I, Rosenhagen M, Holsboer F, Grimm R, Bailey J, Zolotarjova N, Turck CW.

Electrophoresis. 2004 Jul;25(14):2402-12.

PMID:
15274023
9.

Large-scale purification of active platelet integrin glycoprotein IIb-IIIa.

Hillman MC, Zolotarjova NI, Patrick DR, McCabe DD, Shen K, Corman JI, Billheimer JT, Seiffert DA, Hollis GF, Wynn R.

Protein Expr Purif. 2002 Aug;25(3):494-502.

PMID:
12182831
10.

Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated.

Billheimer JT, Dicker IB, Wynn R, Bradley JD, Cromley DA, Godonis HE, Grimminger LC, He B, Kieras CJ, Pedicord DL, Spitz SM, Thomas BE, Zolotarjova NI, Gorko MA, Hollis GF, Daly RN, Stern AM, Seiffert D.

Blood. 2002 May 15;99(10):3540-6.

11.

Absence of post-translational aspartyl beta-hydroxylation of epidermal growth factor domains in mice leads to developmental defects and an increased incidence of intestinal neoplasia.

Dinchuk JE, Focht RJ, Kelley JA, Henderson NL, Zolotarjova NI, Wynn R, Neff NT, Link J, Huber RM, Burn TC, Rupar MJ, Cunningham MR, Selling BH, Ma J, Stern AA, Hollis GF, Stein RB, Friedman PA.

J Biol Chem. 2002 Apr 12;277(15):12970-7. Epub 2001 Dec 31.

12.

Unusually stable and long-lived ligand-induced conformations of integrins.

Zolotarjova NI, Hollis GF, Wynn R.

J Biol Chem. 2001 May 18;276(20):17063-8. Epub 2001 Mar 8.

13.

Sodium pump isoforms in xenotransplantation: importance of biochemical compatibility.

Rose AM, Qazzaz HM, Zolotarjova N, Mellett BJ, Martin AW, Valdes R Jr.

Clin Chem. 2000 Feb;46(2):234-41.

14.

Similarities and differences between the properties of native and recombinant Na+/K+-ATPases.

Xie Z, Wang Y, Liu G, Zolotarjova N, Periyasamy SM, Askari A.

Arch Biochem Biophys. 1996 Jun 1;330(1):153-62.

PMID:
8651690
15.

Interactions of phosphorylation and dimerizing domains of the alpha-subunits of Na+/K(+)-ATPase.

Ganjeizadeh M, Zolotarjova N, Huang WH, Askari A.

J Biol Chem. 1995 Jun 30;270(26):15707-10.

16.

Functional coupling of phosphorylation and nucleotide binding sites in the proteolytic fragments of Na+/K(+)-ATPase.

Zolotarjova N, Periyasamy SM, Huang WH, Askari A.

J Biol Chem. 1995 Feb 24;270(8):3989-95.

17.

Different sensitivities of native and oxidized forms of Na+/K(+)-ATPase to intracellular proteinases.

Zolotarjova N, Ho C, Mellgren RL, Askari A, Huang WH.

Biochim Biophys Acta. 1994 Jun 1;1192(1):125-31.

PMID:
8204642
18.

Different sensitivities of the Na+/K(+)-ATPase isoforms to oxidants.

Huang WH, Wang Y, Askari A, Zolotarjova N, Ganjeizadeh M.

Biochim Biophys Acta. 1994 Feb 23;1190(1):108-14.

PMID:
8110803

Supplemental Content

Loading ...
Support Center